These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 649987)

  • 41. Aspects on antibacterial treatment of anaerobic infections.
    Nordbring F; Nord CE
    Scand J Infect Dis Suppl; 1982; 35():59-62. PubMed ID: 6762654
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative efficacy of ceftriaxone in experimental infections involving Bacteroides fragilis and Escherichia coli.
    Dezfulian M; Bitar RA; Bartlett JG
    Chemotherapy; 1993; 39(5):355-60. PubMed ID: 8370326
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of metronidazole on Escherichia coli in the presence of Bacteroides fragilis: an investigation in mice.
    Reznikov M; McDonald PJ
    Chemotherapy; 1983; 29(3):225-9. PubMed ID: 6347547
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics of penicillin-G in serum and nasal washings of Pasteurella multocida free and infected rabbits.
    Welch WD; Lu YS; Bawdon RE
    Lab Anim Sci; 1987 Feb; 37(1):65-8. PubMed ID: 3586607
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bactericidal activity of metronidazole against Bacteroides fragilis.
    Whelan JP; Hale JH
    J Clin Pathol; 1973 Jun; 26(6):393-5. PubMed ID: 4718964
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunological detection of Bacteroides fragilis in clinical samples.
    Patrick S; Stewart LD; Damani N; Wilson KG; Lutton DA; Larkin MJ; Poxton I; Brown R
    J Med Microbiol; 1995 Aug; 43(2):99-109. PubMed ID: 7629860
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The influence of steroids on the penetration of antibiotics into brain tissue and brain abscesses. An experimental study in rats.
    Kourtópoulos H; Holm SE; Norrby SR
    J Antimicrob Chemother; 1983 Mar; 11(3):245-9. PubMed ID: 6841306
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pathogenicity of the Bacteroides fragilis group.
    Brook I
    Ann Clin Lab Sci; 1989; 19(5):360-76. PubMed ID: 2679351
    [TBL] [Abstract][Full Text] [Related]  

  • 49. When to use two or more antibiotics.
    Farrar WE
    Am Fam Physician; 1973 Jul; 8(1):120-1. PubMed ID: 4198745
    [No Abstract]   [Full Text] [Related]  

  • 50. Therapeutic efficacy of moxifloxacin, a new quinolone, in the treatment of experimental intra-abdominal abscesses induced by Bacteroides fragilis in mice.
    Thadepalli H; Chuah SK; Gollapudi S
    Chemotherapy; 2004 Jun; 50(2):76-80. PubMed ID: 15211081
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Letter: Meningitis caused by Bacteroides fragilis and mastoiditis caused by anaerobic bacteria after cranial injury].
    Drugeon H; Moinard D; Courtieu AL; Gaschignard JL; Legent F
    Nouv Presse Med; 1976 Mar; 5(13):865. PubMed ID: 1046166
    [No Abstract]   [Full Text] [Related]  

  • 52. Neonatal pneumonia caused by members of the Bacteroides fragilis group.
    Brook I; Martin WJ; Finegold SM
    Clin Pediatr (Phila); 1980 Aug; 19(8):541-4. PubMed ID: 7389240
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Failure of penicillin in anaerobic necrotizing pneumonia.
    Panwalker AP
    Chest; 1982 Oct; 82(4):500-1. PubMed ID: 7116968
    [No Abstract]   [Full Text] [Related]  

  • 54. Fluid and penicillin G dynamics in polyethylene chambers implanted subcutaneously in rabbits.
    Tight RR; Prior RB; Perkins RL; Rotilie CA
    Antimicrob Agents Chemother; 1975 Oct; 8(4):495-7. PubMed ID: 1190755
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of Enzyme Preparations upon Penicillin: II. Agents Responsible for Penicillin Inactivation.
    Lawrence CA
    J Bacteriol; 1945 Jan; 49(1):57-63. PubMed ID: 16560896
    [No Abstract]   [Full Text] [Related]  

  • 56. β-Lactamase-Producing Bacteria in Upper Respiratory Tract Infections.
    Brook I
    Curr Infect Dis Rep; 2010 Mar; 12(2):110-7. PubMed ID: 21308507
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of beta-lactamase-producing-bacteria in mixed infections.
    Brook I
    BMC Infect Dis; 2009 Dec; 9():202. PubMed ID: 20003454
    [TBL] [Abstract][Full Text] [Related]  

  • 58. beta-Lactamase-mediated inactivation and efficacy of cefazolin and cefmetazole in Staphylococcus aureus abscesses.
    Fields MT; Herndon BL; Bamberger DM
    Antimicrob Agents Chemother; 1993 Feb; 37(2):203-6. PubMed ID: 8452349
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Failure of single doses of cefazolin and cefamandole to penetrate experimental chronic Escherichia coli abdominal abscesses.
    Gerding DN; Kozak AJ; Peterson LR; Hall WH
    Antimicrob Agents Chemother; 1980 Jun; 17(6):1023-9. PubMed ID: 6996611
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cefoxitin inactivation by Bacteroides fragilis.
    Cuchural GJ; Tally FP; Jacobus NV; Marsh PK; Mayhew JW
    Antimicrob Agents Chemother; 1983 Dec; 24(6):936-40. PubMed ID: 6660860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.